A surgically precise e-mail hacking effort is targeting health care companies in an effort to steal corporate secrets for insider stock trading.
While the hacking techniques are relatively common, experts at FireEye, the Silicon Valley IT security firm that revealed the hacking group Monday, were surprised by the attackers' business savvy and sustained attention on specific targets. The focus allowed them to breach e-mail accounts of top executives, lawyers, bankers, consultants and investor-relations departments at more than 100 large companies, which were not named.
Medical device firms and pharmaceutical makers are being targeted because they're prone to large stock swings from disclosures like announcements of potential mergers, product approvals and clinical trial results. Nearly 70 percent of the companies in the report were publicly traded health care companies, and more than a quarter of them make medical devices and equipment.
Such precise targeting of individuals with financial information separated this group of hackers from others who might be interested in stealing national secrets or causing general havoc.
So far, no trades of stock have been linked to information stolen from executives' e-mails by FIN4. FireEye said it has informed the FBI about the attacks it has detected.
"Given that this group is so tailored in its approach, and they seem very knowledgeable about how the markets work, to us [insider trading] was the only plausible explanation for what we were seeing," said Jen Weedon, manager of threat intelligence for FireEye, which dubbed the hacking group FIN4.
FireEye is an influential cybersecurity firm that counts more than 150 of the Fortune 500 as clients. In January it paid $1 billion to buy computer-forensics company Mandiant.
FireEye didn't specifically name the targeted companies because they are clients that have confidentiality agreements. Several large medical device makers in Minnesota declined to comment about whether they'd been targeted by hackers seeking information about upcoming mergers or product approvals.